Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02746393 · ClinicalTrials.gov registry record · NA

SFGH Health Advocates Stage II Study

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
1,278
Enrollment target

NCT02746393 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,278 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02746393, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
1,278 participants
Enrollment target

Study Summary

The San Francisco General Hospital (SFGH) Health Advocate Staff II Study is a Randomized Controlled Trial (RCT) that collects survey data and non-invasive biological data from caregivers and children visiting a pediatric urgent care center. Families will be randomized according to a pre-determined randomization schedule into one of two social needs-focused interventions (the Health Advocates Program or a 211 Information active comparator arm). All patients in the study will be followed over a six month period to capture information about changes in social needs, health and health care utilization.

Interventions

  • OTHER Health Advocates Program
  • OTHER 211 Information Sheet

Trial Details

FieldValue
Enrollment Target 1,278 participants
Start Date 2016-07
Est. Completion 2020-07
Phase NA

What the Registry Record Tells You About NCT02746393

The ClinicalTrials.gov registry entry for NCT02746393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Health Advocates Program is the first listed.

NCT02746393 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02746393 about?

NCT02746393 is a clinical study titled "SFGH Health Advocates Stage II Study". The San Francisco General Hospital (SFGH) Health Advocate Staff II Study is a Randomized Controlled Trial (RCT) that collects survey data and non-invasive biological data from caregivers and children visiting a pediatric urgent care center. Families will be randomized according to a pre-determined r...

What is the current status of trial NCT02746393?

This trial is currently completed. It is a NA study. The enrollment target is 1,278 participants. The study started on 2016-07. Estimated completion is 2020-07.

What interventions are being tested in trial NCT02746393?

The interventions under investigation include: Health Advocates Program (OTHER), 211 Information Sheet (OTHER).

Who is sponsoring clinical trial NCT02746393?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.